### Genetic association study [Tresukosol, et al. PLoS One. 2014​](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0110188) ###
**Title : Effects of Cytochrome P450 2C19 and Paraoxonase 1 Polymorphisms on Antiplatelet Response to Clopidogrel Therapy in Patients with Coronary Artery Disease**
| No. |  Questions from the research article  | No. | Knowledge topics to gain more understanding|
|:----------: | -----------| :-----------: | ----------- |
|  1 |  What is an odds ratio, and how do you calculate it?  | 1  |   inter-individual variability |
|  2 |  What is the difference between the Chi-square goodness-of-fit test and Fisher’s exact test?  |  2 | susceptibility gene   |
|  3 |  Can we use multiple Student’s t-tests instead of one-way ANOVA? Are we still getting the accurate results?  |  3  | allelic association  |
|  4 |  What are univariable and multivariable logistic regression and how it is different from each other?  | 4  |  epistatic interaction  |
|  5 |  How does the does the Chi-square goodness-of-fit test differ from the Chi-square test?  | 5  |  metabolizer phenotype  |
|  6 |  What is Bonferroni’s method, and how does it work?  |   |    |
|  7 |  What is Cordell’s test, and how does it work?  |    |   |
|  8 |  What is Likelihood ratio test, and how does it work?  |    |   |
|  9 | What is the simple logistic regression model, and what makes it different from other models? |  |  |
|  10 | What do *2 and *3 mean in CYP2C19*2 and *3? And what is the difference between them? |   |   |
|  11 | What is multiple electrode platelet aggregometry (MEA), and how does it work? |  |  |
| 12 | What are the guanidine-HCl methods, and how does it work? |  |  |
| 13 | How to calculate linkage disequilibrium (LD), and what standardized LD coefficient (D') and correlation coefficient (r) are represented? |  |  |
| 14 | What is the difference between a combined effect and a co-dominant effect? |  |  |


### Sequencing and annotation [Suktitipat, et al. PLoS One. 2017](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0180056) ###
**Title : Molecular investigation by whole exome sequencing revealed a high proportion of pathogenic variants among Thai victims of sudden unexpected death syndrome**
| No. | Questions from the research article   | No.   | Knowledge topics to gain more understanding|
|:-----------:| ----------- | :-----------:| ----------- |
|  1 |  What is the difference between detailed autopsy and molecular autopsy?  |  1  |  transcript ablation |
|  2 |  How does the missense mutation differ from other mutations?  |  2  |  confers sensitivity |
|  3 |  What is the difference between a reference allele and an alternative allele?  |  3   | pathogenicity  |
|  4 |  What information is stored in the dbNSFP database?  |  4   | allelic heterogeneity |
|  5 |  What information is stored in ClinVar?  |   5 | genetic heterogeneity  |
|  6 |  What is metaSVM?  |  6  |  double heterozygote |
| 7  |  What is prophylactic treatment, and how many types does it have?   | 7  |  Sequence ontology  |
| 8  | Is whole exome sequencing (WES) the most commonly used in all next-generation sequencing (NGS)? And why does it be? | 8 | Deleterious variant |
| 9  | How can we know which database to use for filtering variants based on minor allele frequency (MAF)? Is there any criteria for this? |   |    |

